HRT Financial’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,665
Closed -$58K 4463
2025
Q4
$58K Buy
+15,665
New +$134K ﹤0.01% 2858
2025
Q2
Sell
-14,818
Closed -$163K 3294
2025
Q1
$163K Buy
+14,818
New +$177K ﹤0.01% 2069
2024
Q3
Sell
-9,205
Closed -$531K 2923
2024
Q2
$531K Buy
+9,205
New +$451K ﹤0.01% 1276
2024
Q1
Sell
-10,160
Closed -$824K 2864
2023
Q4
$824K Buy
+10,160
New +$827K 0.01% 1086
2023
Q3
Sell
-1,556
Closed -$510K 2895
2023
Q2
$510K Buy
1,556
+729
+88% +$222K ﹤0.01% 1354
2023
Q1
$228K Sell
827
-1,356
-62% -$498K ﹤0.01% 1865
2022
Q4
$845K Buy
+2,183
New +$616K 0.01% 1064

Other funds holding OM

HRT Financial's OM Position: Q1 2026 in Review

HRT Financial sold out of Outset Medical (OM) in Q1 2026, closing a stake of 15,665 shares — an estimated $58K sold.

HRT Financial first reported a position in OM in Q4 2022 and held it in 7 quarters. The position peaked at $845K in Q4 2022. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • HRT Financial reported no remaining Outset Medical position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 15,665 Outset Medical shares in Q1 2026, an estimated $58K.
  • HRT Financial first reported a position in Outset Medical in Q4 2022 and held it in 7 quarters.
  • HRT Financial's Outset Medical position peaked at $845K in Q4 2022.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.